FDA Clears Darunavir Tablets for Approval

Summary

The US Food and Drug Administration has ruled that the 400mg version of the HIV medication Darunavir, sold under the brand name PREZISTA, was not removed from the market due to safety or efficacy concerns, paving the way for potential approval of generic versions.